Inventor · disambiguated record
Franck Laurent Brebion
Also filed as: BREBION FRANCK · BREBION FRANCK LAURENT
6 granted patents·3 pending applications·10 citations·filing 2007–2021
73Inventor score
Top patents by PatentIndex Score
9 records- 0190US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0288US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0369US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 0468US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 0544US2007260041A1Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfidesCRICH DAVID·Filed 2007·Application pending·0 cites
- 0644US2010222549A1Dechalcogenative methods for the preparation of allylic sulfidesCRICH DAVID·Filed 2008·Application pending·0 cites
- 0738US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 0837US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 0937US2021315893A1Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosisGALAPAGOS NV·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Franck Laurent Brebion files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →